Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma Leticia García-Mochón, Manuel David Gil-Sierra, Emilio Jesús Alegre-del Rey, Catalina Alarcón de la Lastra-Romero, Marina Sánchez-Hidalgo

Economic evaluation in collaborative hospital drug evaluation reports Ana Ortega, María Dolores Fraga, Roberto Marín-Gil, Eduardo López-Briz, Francesc Puigventós, George Dranitsaris

Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain Estela Moreno-Martínez, Javier de la Serna-Torraba, Vicente Escudero-Vilaplana, José Ángel Hernández-Rivas, Marina Sánchez-Cuervo, Raquel Sánchez-Hernández